Cord blood stem cells and regenerative medicine

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Umbilical cord blood (CB) can provide a virtually unlimited source of diverse stem cells that can be used for hematologic transplants as well as in a variety of regenerative medicine applications. Cord blood units can be frozen and preserved in liquid nitrogen dewars for prolonged periods of time, having been frozen in time at the peak of their biological activity. Multipotent stem cells are available in large numbers in both umbilical cord blood (CB) and cord tissue (CT). CB stem cells are capable of giving rise to hematopoietic, epithelial, endothelial, and neural tissues both in vitro and in vivo. CT stem cells are capable of giving rise to various mesenchymal lineages, including bone, cartilage, and fat. Thus, CB and CT stem cells are candidates to develop stem-cell-based therapies for a wide variety of diseases, including cardiovascular, ophthalmic, orthopedic, neurological, and endocrine diseases. CB and CT have now been used in several regenerative medicine clinical studies, examples of which include cerebral palsy and non-healing bone fractures. CB and CT represent an invaluable source of stem cells that have both immediate and future applications for the individual donor.

Original languageEnglish (US)
Title of host publicationRegenerative Medicine and Cell Therapy
PublisherHumana Press Inc.
Pages301-312
Number of pages12
ISBN (Electronic)9781627030977
ISBN (Print)9781627030984
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Cord blood stem cells and regenerative medicine'. Together they form a unique fingerprint.

Cite this